Ribociclib-Letrozole Regimen Tested in Ovarian, Endometrial Cancer
Researchers examined the results of ribociclib and letrozole as a treatment for patients with estrogen receptor-positive ovarian cancer and endometrial cancer.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Dave Levitan Source Type: news